ClearTrial Appoints New COO

Friday, March 27, 2009 11:17 AM

ClearTrial, a provider of clinical trial software, appointed Michael Bruns as the company’s new chief operating officer. Bruns will oversee ClearTrial’s global operations and help further develop and implement the company’s growth strategy. Prior to joining ClearTrial, Bruns was director of the Technology Investment Banking Group at Robert W. Baird, a global investment banking firm.

Other personnel news from the clinical trial industry:

Chinese CRO WuXi expanded its senior leadership with the appointment of three new executives. Brian Xu is vice president of toxicology and head of the Safety Evaluation Center at Suzhou; Yang-Dar Yuan is vice president of operations and head of pathology of the Safety Evaluation Center, and Robert Coldreck is head of Good Laboratory Practice Quality Assurance.

UK-based site management organization Synexus hired three new managers. Noreen Younis is the new feasibility manager with responsibility for the preparation of detailed feasibility analysis for each clinical trial that Synexus is invited to tender for. Joanne Lee is the contact center manager handling all call center activity. Liz Smith takes on the new role of patient outreach manager and will oversee all patient enrollment programs.

etrials appointed E. James Emerson, Ph.D., vice president of technology and development. Emerson served as a consultant for the eClinical company before joining full-time. He previously has served as head of technology for several companies.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs